In our daily series of Q&As, we profile Lodestone Energy managing director Gary Holden.
TRG Natural Pharmaceuticals was placed into liquidation in December, much to the surprise of its minor shareholders.
Commerce Commission’s final report on business fees ‘fell short’ for consumers.
Following successful clinical trials, her R&D discovery company is hoping to exit via big pharma.
A leaked memo says liquidators will be assessing transactions to ensure they have been conducted properly.
Cameron Partners has been tapped for the deal, while Fullers360 says it won’t comment on ‘market speculation’.
Exempting employer contributions to life and health insurance from FBT will remove a key barrier to uptake, the Financial Services Council suggests.
The receivers of two entities behind the premium pet food brand sold their assets to a subsidiary of dual-listed Ebos in February.
Business group and event Revved was created in response to the fallout from last year’s David Goggins controversy.
New global report finds Auckland’s world-class liveability threatened by persistent productivity lags.
